Generalized cutaneous candidiasis is a comparatively rare chronic infection usually involving the face, ears, neck, upper chest, and mouth. The infection occurs in prepubertal children, and often there are associated ectodermal abnormalities. There is a tendency to form thick, dry, brownish crusts with only a mild inflammatory reaction. Mycelia and spores are invariably present in the lesions. Treatment of this condition has been unsatisfactory, and the outcome is usually fatal.1,2 Recently there have been several reports on the use of amphotericin B in the treatment of systemic candidiasis, a condition which is most often encountered in patients who have received steroid and antibiotic therapy and in patients who have undergone intestinal surgery.3,4This agent has been moderately successful except in cases in which there was endocarditis or central nervous system involvement.4,5In some cases there has been apparent biologic cure.4-6To our knowledge the use of